CN110959863A - Stevia rebaudiana leaf mixed nutrient syrup and preparation method and application thereof - Google Patents
Stevia rebaudiana leaf mixed nutrient syrup and preparation method and application thereof Download PDFInfo
- Publication number
- CN110959863A CN110959863A CN201911288732.4A CN201911288732A CN110959863A CN 110959863 A CN110959863 A CN 110959863A CN 201911288732 A CN201911288732 A CN 201911288732A CN 110959863 A CN110959863 A CN 110959863A
- Authority
- CN
- China
- Prior art keywords
- stevia rebaudiana
- syrup
- extract
- extraction
- nutrient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000228451 Stevia rebaudiana Species 0.000 title claims abstract description 128
- 235000006092 Stevia rebaudiana Nutrition 0.000 title claims abstract description 97
- 235000020357 syrup Nutrition 0.000 title claims abstract description 89
- 239000006188 syrup Substances 0.000 title claims abstract description 89
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 71
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 116
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 52
- 239000000463 material Substances 0.000 claims abstract description 37
- 206010067125 Liver injury Diseases 0.000 claims abstract description 29
- 238000002156 mixing Methods 0.000 claims abstract description 27
- 235000021419 vinegar Nutrition 0.000 claims abstract description 24
- 239000000052 vinegar Substances 0.000 claims abstract description 23
- 231100000753 hepatic injury Toxicity 0.000 claims abstract description 22
- 238000001914 filtration Methods 0.000 claims abstract description 19
- 238000003756 stirring Methods 0.000 claims abstract description 18
- 238000011049 filling Methods 0.000 claims abstract description 14
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 14
- 230000001954 sterilising effect Effects 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 11
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 10
- 239000003765 sweetening agent Substances 0.000 claims abstract description 10
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 7
- 239000000796 flavoring agent Substances 0.000 claims abstract description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 46
- 239000003814 drug Substances 0.000 claims description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 31
- 239000012528 membrane Substances 0.000 claims description 22
- 238000004108 freeze drying Methods 0.000 claims description 19
- 238000001035 drying Methods 0.000 claims description 18
- 239000000919 ceramic Substances 0.000 claims description 16
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 229940088598 enzyme Drugs 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 12
- 235000013305 food Nutrition 0.000 claims description 12
- 238000002137 ultrasound extraction Methods 0.000 claims description 12
- 238000004140 cleaning Methods 0.000 claims description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 10
- 238000000108 ultra-filtration Methods 0.000 claims description 10
- 238000003809 water extraction Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 108010059892 Cellulase Proteins 0.000 claims description 8
- 229940106157 cellulase Drugs 0.000 claims description 8
- 230000009849 deactivation Effects 0.000 claims description 8
- 240000000111 Saccharum officinarum Species 0.000 claims description 7
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 229940088594 vitamin Drugs 0.000 claims description 7
- 229930003231 vitamin Natural products 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 239000011782 vitamin Substances 0.000 claims description 7
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 6
- 229910000831 Steel Inorganic materials 0.000 claims description 6
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 6
- 235000011477 liquorice Nutrition 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000010959 steel Substances 0.000 claims description 6
- 241001076416 Dendrobium tosaense Species 0.000 claims description 5
- 235000021120 animal protein Nutrition 0.000 claims description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 5
- 108010064851 Plant Proteins Proteins 0.000 claims description 4
- 235000021118 plant-derived protein Nutrition 0.000 claims description 4
- 235000013402 health food Nutrition 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 239000012676 herbal extract Substances 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 45
- 230000000694 effects Effects 0.000 abstract description 27
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 24
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 abstract description 8
- 229940013618 stevioside Drugs 0.000 abstract description 8
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 abstract description 8
- 235000019202 steviosides Nutrition 0.000 abstract description 8
- 201000001421 hyperglycemia Diseases 0.000 abstract description 5
- 208000007530 Essential hypertension Diseases 0.000 abstract description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 31
- 230000000052 comparative effect Effects 0.000 description 25
- 241000699670 Mus sp. Species 0.000 description 24
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 15
- 108010082126 Alanine transaminase Proteins 0.000 description 15
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 15
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 15
- 210000002966 serum Anatomy 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 244000269722 Thea sinensis Species 0.000 description 11
- VZGDMQKNWNREIO-UHFFFAOYSA-N carbon tetrachloride Substances ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 10
- 235000015110 jellies Nutrition 0.000 description 10
- 239000008274 jelly Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000006872 improvement Effects 0.000 description 9
- 235000006468 Thea sinensis Nutrition 0.000 description 8
- 235000020279 black tea Nutrition 0.000 description 8
- 238000007710 freezing Methods 0.000 description 8
- 230000008014 freezing Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 102000007544 Whey Proteins Human genes 0.000 description 7
- 108010046377 Whey Proteins Proteins 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 235000021119 whey protein Nutrition 0.000 description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 231100000439 acute liver injury Toxicity 0.000 description 6
- 238000009928 pasteurization Methods 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 108010084695 Pea Proteins Proteins 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000005228 liver tissue Anatomy 0.000 description 5
- 235000019702 pea protein Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 229960002433 cysteine Drugs 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 102000004407 Lactalbumin Human genes 0.000 description 3
- 108090000942 Lactalbumin Proteins 0.000 description 3
- 244000275012 Sesbania cannabina Species 0.000 description 3
- 240000004584 Tamarindus indica Species 0.000 description 3
- 235000004298 Tamarindus indica Nutrition 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 229940023476 agar Drugs 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000003345 hyperglycaemic effect Effects 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- 238000010172 mouse model Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000015277 pork Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 229960004441 tyrosine Drugs 0.000 description 3
- 235000002374 tyrosine Nutrition 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 244000288157 Passiflora edulis Species 0.000 description 2
- 235000000370 Passiflora edulis Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 201000006490 Spondylolysis Diseases 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 240000000851 Vaccinium corymbosum Species 0.000 description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 235000015197 apple juice Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 235000021014 blueberries Nutrition 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 229960002449 glycine Drugs 0.000 description 2
- 235000019674 grape juice Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 235000020429 malt syrup Nutrition 0.000 description 2
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical group Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 2
- JMZOMFYRADAWOG-UHFFFAOYSA-N methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate Chemical group COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1C(=O)OC JMZOMFYRADAWOG-UHFFFAOYSA-N 0.000 description 2
- 229930189775 mogroside Natural products 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- NEGYEDYHPHMHGK-UHFFFAOYSA-N para-methoxyamphetamine Chemical compound COC1=CC=C(CC(C)N)C=C1 NEGYEDYHPHMHGK-UHFFFAOYSA-N 0.000 description 2
- 235000021400 peanut butter Nutrition 0.000 description 2
- 235000021422 persimmon vinegar Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- 235000013930 proline Nutrition 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 240000004153 Hibiscus sabdariffa Species 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- -1 decoctions Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000015201 grapefruit juice Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000020339 pu-erh tea Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940082632 vitamin b12 and folic acid Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000009046 yacon syrup Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention provides a preparation method of stevia rebaudiana leaf mixed nutrient syrup, which at least comprises stevia rebaudiana leaf extract, nutrient extract, sweetener, brewed vinegar, fruit juice and a flavoring agent, and the preparation method comprises the following steps: step (1), mixing stevia rebaudiana leaf extract, nutrient materials, sweetener, brewed vinegar, fruit juice and a regulator, adding water, and stirring uniformly to fully dissolve the mixture; standing for 24 hours, filtering, adding water to a specified amount, decocting with slow fire while stirring, decocting until the relative density is 3-5, and stopping heating; and (3) standing for 24 hours, filling and sterilizing to obtain the product. The active extract has obvious liver protection effect on chemical liver injury and alcoholic liver injury. The stevia rebaudiana leaf mixed nutrient syrup reduces the sugar content of the syrup, and the stevioside component can obviously improve the sweetness of the syrup without increasing the blood sugar content of eaters, so that the stevia rebaudiana leaf mixed nutrient syrup can be eaten by diabetics, essential hypertension patients, hyperglycemia patients and hyperlipidemia patients. The invention solves the problem that the common syrup has no health care value.
Description
Technical Field
The invention relates to the technical field of food processing, and particularly relates to stevia rebaudiana leaf mixed nutrient syrup and a preparation method and application thereof.
Background
Syrups are viscous, high-concentration sugar-containing solutions prepared by cooking or other techniques. The raw material for making syrup may be sugar water, sugar cane juice, fruit juice or other plant juice, etc. Since the sugar content of the syrup is very high, it can be preserved for a long time in a sealed state without refrigeration. The syrup can be used for preparing beverages or making sweets.
The method is based on syrup, and stevia rebaudiana leaves are selected as raw materials, so that the obtained stevia rebaudiana leaf mixed nutrient syrup has a good protection effect on liver injury after being eaten, a plurality of lung moistening syrups, cough relieving syrups, sore throat relieving syrups and the like are prepared in the prior art, but the preparation of the stevia rebaudiana leaf mixed nutrient syrup for preventing and treating liver injury is not reported at present. Meanwhile, the low-fat low-calorie syrup has the characteristics of low fat and low calorie, and is prepared by mixing nutrient materials such as vitamins, amino acids, animal proteins, plant proteins or traditional Chinese medicines and the like to supplement nutrient substances required by a human body, so that the healthy and low-calorie syrup is complementary to the deficiency of daily diet and is beneficial to the health of people after being eaten for a long time.
Stevia belongs to Compositae, also called stevia rebaudiana and sweet grass, is a perennial wild herb of Compositae. Stevia leaves contain a large amount of stevioside, the content of the stevioside accounts for about 10 percent, the stevioside is a natural sweetener, and the stevioside is internationally endowed with the names of 'plant sugar king', 'best natural sweetener' and the like. It can be used to replace various chemically synthesized sweeteners such as sugar and saccharin, and can be widely used in food, beverage, medicine, daily chemical industry, wine brewing, and cosmetics. The food beverage prepared from the edible oil can not make people fat after long-term eating, and is especially suitable for patients with obesity, diabetes, hypertension, arteriosclerosis, dental caries, etc. In recent years, the research on stevia rebaudiana leaves at home and abroad mainly focuses on the extraction and application of stevioside, and the research on the capability of the stevia rebaudiana leaves in protecting chemically damaged liver and preventing and treating liver damage is not reported yet.
Disclosure of Invention
The invention provides a stevia rebaudiana leaf mixed nutrient syrup and a preparation method thereof, and aims to provide the stevia rebaudiana leaf mixed nutrient syrup, wherein an active extract of the stevia rebaudiana leaf mixed nutrient syrup is prepared by adopting water soaking and supercritical fluid extraction, and the extracted stevia rebaudiana leaf extract is mixed with nutrient materials such as traditional Chinese medicine extract, vitamins, animal protein, plant protein, amino acid and the like, so that the stevia rebaudiana leaf mixed nutrient syrup can be used for preparing health-care products or food for preventing and treating various types of liver protection, can obviously improve the sweetness of the syrup without increasing the blood sugar content of eaters, and can be eaten by diabetics, essential hypertension patients, hyperglycemia patients and hyperlipidemia patients. The invention solves the problem that the common syrup has no health care value.
The invention provides a preparation method of stevia rebaudiana leaf mixed nutrient syrup, which at least comprises stevia rebaudiana leaf extract, nutrient extract, sweetener, brewed vinegar, fruit juice and a flavoring agent, and the preparation method comprises the following steps:
step (1), mixing stevia rebaudiana leaf extract, nutrient materials, sweetener, brewed vinegar, fruit juice and a regulator, adding water, and stirring uniformly to fully dissolve the mixture;
standing for 24 hours, filtering, adding water to a specified amount, decocting with slow fire while stirring, decocting until the relative density is 3-5, and stopping heating;
and (3) standing for 24 hours, filling and sterilizing to obtain the product.
Preferably, after the step (3), the method further comprises: and (4a) mixing the stevia rebaudiana leaf mixed nutrient syrup into one of pure water, milk, fruit juice, almond juice, soybean milk, cream, light cream, sour cream, cheese, yoghourt, snow lamb, vinegar, fruit vinegar, black tea, milk tea, coffee, cocoa powder beverage, traditional Chinese medicine liquid, western medicine liquid, natural fruit juice, artificial fruit juice, assam black tea, Ceylon black tea, Burju black tea, Litton black tea, Pu' er tea, black tea powder and coarse tea and uniformly stirring.
Preferably, after the step (3), the method further comprises: and (4b) mixing the syrup with one of syrup jelly, milk jelly, almond jelly, soybean milk jelly, black tea jelly, milk tea jelly, coffee jelly, cocoa powder jelly and Chinese medicinal liquid jelly, and uniformly mixing.
Preferably, after the step (3), the method further comprises: and (4c) mixing the syrup with one of cake, biscuit, peanut butter, jam and liquor and uniformly mixing.
Preferably, the sterilization method is pasteurization, specifically heating the syrup to 62-65 deg.C, and maintaining for 30 min.
Preferably, the sweetening agent is selected from one or more of inulin, mogroside, erythritol, malt syrup, yacon syrup and sorbitol, the brewing vinegar is selected from one or more of glutinous rice vinegar, black vinegar, red vinegar, persimmon vinegar, apple vinegar, red date vinegar, rose vinegar, peach blossom vinegar and roselle vinegar, the fruit juice is selected from one or more of lemon juice, orange juice, apple juice, watermelon juice, grape juice, grapefruit juice, passion fruit juice and blueberry juice, and the blending agent is selected from one or more of Arabic gum, tamarind polysaccharide gum, sesbania gum, agar, xanthan gum, β -cyclodextrin and propylene glycol alginate.
As a further improvement of the invention, the stevia rebaudiana leaf extract is prepared by the following method:
s1, cleaning stevia rebaudiana leaves, cutting into pieces, adding the stevia rebaudiana leaves into pure water for soaking, performing ultrasonic-assisted extraction for 30min, filtering, reserving filter residues, and freeze-drying filtrate to obtain water extract freeze-dried powder;
s2, filling the filter residue obtained in the step S1 into an extraction kettle, and opening CO2The steel cylinder is used for carrying out supercritical fluid extraction, after the extraction is finished, a valve of the extraction kettle is opened, the extract is collected and dried at low temperature, and the supercritical fluid extract is obtained;
the extraction conditions were:
extraction pressure: 21-24 MPa; the extraction temperature is as follows: 45-50 ℃; CO 22Flow rate: 6-9L/h; extraction time: 2 h; entrainer: water and ethanol in a volume ratio of 3: 1;
s3, uniformly mixing the water extraction freeze-dried powder obtained in the step S1 and the supercritical fluid extract obtained in the step S2 to obtain the stevia rebaudiana leaf extract.
As a further improvement of the invention, the ultrasonic power is 1500-2000W, the freeze drying condition is that the mixture is frozen at-15 ℃ for 30min and then cooled to-35 ℃ for 10h, and the low-temperature drying is drying at-5 ℃ for 1 h.
As a further improvement of the invention, the mass ratio of the stevia rebaudiana leaf extract to the nutrient material to the sweetener to the brewed vinegar to the fruit juice to the blending agent is 100 (5-10): 2: (3-7): (10-20): (2-5).
As a further improvement of the invention, the nutrient material is selected from one or a mixture of several of traditional Chinese medicine extract, vitamins, animal protein, plant protein and amino acid.
Preferably, the vitamin is one or a mixture of several selected from vitamin A, vitamin C, vitamin E, B family vitamin, vitamin D and vitamin K.
Preferably, the amino acid is selected from one or more of glycine, alanine, valine, leucine, isoleucine, phenylalanine, proline, tryptophan, tyrosine, serine, cysteine, methionine, asparagine, glutamine, threonine, aspartic acid, glutamic acid, lysine, arginine and histidine.
Preferably, the animal protein is selected from one or more of whey protein, collagen, beef powder, pork powder and chicken powder. The pork powder and chicken powder are prepared by oven drying fresh pork or chicken until the water content is less than 5%, and pulverizing.
Preferably, the vegetable protein is selected from one or more of bean protein, pea protein, corn protein, hydrolyzed wheat protein and peanut protein.
As a further improvement of the invention, the traditional Chinese medicine extract comprises the following raw materials in parts by weight: 100-200 parts of liquorice, 50-120 parts of sugarcane and 10-20 parts of dendrobium officinale.
As a further improvement of the invention, the traditional Chinese medicine extract is prepared by the following method:
s1, pretreatment: weighing the raw medicinal materials according to a certain proportion, cleaning, drying and crushing to obtain traditional Chinese medicine powder for later use;
s2, extraction: adding the Chinese medicinal powder into pure water, adding cellulase, adjusting pH and temperature, performing enzymolysis for 0.5-1 hr, inactivating enzyme, adding sodium carbonate to adjust pH to neutral, performing ultrasonic-assisted extraction for 1-3 hr, centrifuging, collecting supernatant, concentrating, and freeze drying to obtain Chinese medicinal extract.
As a further improvement of the invention, the pH value is adjusted to 5, the temperature is adjusted to 45-60 ℃, the enzyme deactivation method is heating at 100 ℃ for 10min, the ultrasonic power is 1200-1500W, the centrifugation condition is 4 ℃, 10000-12000r/min centrifugation is 5min, the freeze drying condition is freezing at-10 ℃ for 15min and freezing at-30 ℃ for 12h, and the mass-volume ratio of the traditional Chinese medicine powder to the pure water is 1: (5-10); the addition amount of the cellulase is 1000-1200U/kg, the concentration method adopts ceramic membrane ultrafiltration, the aperture of the ceramic membrane is 0.05-0.10 mu m, and the operation conditions of the ceramic membrane ultrafiltration are as follows: the transmembrane pressure difference is 0.17-0.30MPa, the filtration temperature is 52-57 ℃, and the membrane surface flow rate is 7-10 m/s.
The invention further protects the application of the stevia rebaudiana leaf mixed nutrient syrup in preparing health-care food or food for preventing and treating liver injury.
In a further improvement of the present invention, the liver injury is chemical liver injury or alcoholic liver injury.
Preferably, the health food is prepared into tablets, injections, capsules, granules, pills, decoctions, syrups and mixtures.
The invention has the following beneficial effects: on the basis of the research on the original chemical components and the traditional efficacy of the stevia rebaudiana leaves, the active extract is prepared by simultaneously adopting water soaking and supercritical fluid extraction, and compared with the prior art, the extracted stevia rebaudiana leaf extract can obviously reduce CCl4Or ALT and AST activity in serum of a model mouse with alcohol-induced liver injury and liver tissue MDA content, and liver SOD activity are enhanced, which shows that the active extract has obvious liver protection effect on chemical liver injury and alcoholic liver injury. Therefore, the stevia rebaudiana leaf extract is expected to be developed into a new generation of safe and effective medicine, health-care product or food for preventing and treating various types of liver protection.
The stevia rebaudiana leaf mixed nutrient syrup provided by the invention reduces the sugar content of the syrup, the stevioside component can obviously improve the sweetness of the syrup without increasing the blood sugar content of eaters, can be eaten by diabetics, essential hypertension patients, hyperglycemia patients and hyperlipidemia patients, further has the effects of reducing blood pressure, blood sugar, blood fat and the like, and has wide application prospect.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without creative efforts.
FIG. 1 is a graph showing a comparison of blood glucose levels at different times in each group of mice in test example 2 of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Test methods in which specific conditions are not specified in the following examples are generally carried out under conventional conditions or under conditions recommended by the manufacturer.
The comminution operation was carried out with a TRM series mechanical impact mill, supplied by Weifang environmental protection science and technology Limited. Drying was carried out by an SZG double-cone rotary vacuum dryer supplied by Henzhou remote drying apparatus Co. Freeze-drying operation was performed with a vacuum freeze-drying agent provided by Shanghai Toulong Fulong science and technology Co., Ltd; the centrifugal operation is carried out by a PZ flat plate direct-connected centrifuge provided by Toxico Longtai chemical mechanical equipment Co., Ltd; the ultrasonic treatment was carried out by an ultrasonic extraction tank provided by Shandong Baihe Biotechnology Co. The supercritical fluid extraction operation is carried out by supercritical fluid extraction equipment provided by Hainan Hua supercritical equipment limited, and the concentration operation is carried out by ceramic membrane equipment provided by Nanjing Pengheng Membrane technology limited.
Stevia rebaudiana leaves are provided by Jining Ooxing stevia products, Inc.
Cellulase, CAS No. 9012-54-8, was supplied by Shanghai Allantin Biotech Co., Ltd.
Sorbitol, CAS number 50-70-4; inulin, CAS No. 9005-80-5; erythritol, CAS number 149-32-6; maltose syrup, CAS number 69-79-4.
Whey protein, CAS No. 84082-51-9; collagen, CAS number 9064-67-9; pea protein, CAS No. 222400-29-5; beef powder, CAS number 68990-09-0; hydrolyzed wheat protein, CAS number 70084-87-6.
Gum arabic, CAS No. 9000-01-5; tamarind polysaccharide gum CAS No. 39386-78-2; sesbania gum, CAS number 12493-90; agar, CAS number 9002-18-0; carrageenan, CAS number 11114-20-8.
Various vitamins and various amino acids are provided by Zhejiang Kangpu Biotechnology GmbH.
Various brewed vinegars and various fruit juices are provided by fuzhou kangda food ltd.
Sugarcane is sweet in taste and neutral in nature, and has the effects of removing heat and quenching thirst, regulating the middle warmer, and widely separating and draining water. Mainly treats fever, dry mouth, cough due to lung dryness, sore throat, dysphoria with smothery sensation in heart and chest, regurgitation, emesis, and edema during pregnancy. Belongs to a material with homology of medicine and food, and is provided by a traditional Chinese medicine drinking tablet factory of Guangdong province medicinal material company.
The liquorice is sweet in taste and neutral in nature, has the functions of tonifying spleen and qi, clearing away heat and toxic materials, eliminating phlegm and stopping cough, relieving spasm and pain and harmonizing the drugs, and enters heart, lung, spleen and stomach channels. Can be used for treating weakness of spleen and stomach, asthenia, palpitation, short breath, cough, excessive phlegm, abdominal and limb spasm, pain, carbuncle, suppurative sore, and relieving drug toxicity and pungency. Belongs to a material with homology of medicine and food, and is provided by a traditional Chinese medicine drinking tablet factory of Guangdong province medicinal material company.
Example 1Preparation of stevia leaf extract
A method for preparing stevia rebaudiana leaf extract comprises the following steps:
s1, pure water extraction: cleaning stevia rebaudiana leaves, cutting into pieces, adding into pure water, soaking, performing ultrasonic-assisted extraction for 30min at an ultrasonic power of 1500W, filtering, retaining filter residues, freeze-drying the filtrate, and cooling to-35 ℃ for 10h after freezing for 30min under the freeze-drying condition of-15 ℃ to obtain water extract freeze-dried powder;
s2, supercritical fluid extraction: filling the filter residue obtained in the step S1 into an extraction kettle, and opening CO2Performing supercritical fluid extraction in a steel cylinder, opening a valve of an extraction kettle after extraction is finished, collecting extract, and drying at low temperatureDrying at low temperature of-5 deg.C for 1h to obtain supercritical fluid extract;
the extraction conditions were:
extraction pressure: 21 MPa; the extraction temperature is as follows: 45 ℃; CO 22Flow rate: 6L/h; extraction time: 2 h; entrainer: water and ethanol in a volume ratio of 3: 1;
s3, uniformly mixing the water extraction freeze-dried powder obtained in the step S1 and the supercritical fluid extract obtained in the step S2 to obtain the stevia rebaudiana leaf extract, wherein the yield is 82%.
Example 2Preparation of stevia leaf extract
A method for preparing stevia rebaudiana leaf extract comprises the following steps:
s1, pure water extraction: cleaning stevia rebaudiana leaves, cutting into pieces, adding into pure water, soaking, performing ultrasonic-assisted extraction for 30min at an ultrasonic power of 1500W, filtering, retaining filter residues, freeze-drying the filtrate, and cooling to-35 ℃ for 10h after freezing for 30min under the freeze-drying condition of-15 ℃ to obtain water extract freeze-dried powder;
s2, supercritical fluid extraction: filling the filter residue obtained in the step S1 into an extraction kettle, and opening CO2Performing supercritical fluid extraction in a steel cylinder, opening a valve of an extraction kettle after extraction is finished, collecting an extract, and drying at low temperature, wherein the drying at low temperature is-5 ℃ for 1h to obtain a supercritical fluid extract;
the extraction conditions were:
extraction pressure: 24 MPa; the extraction temperature is as follows: 50 ℃; CO 22Flow rate: 9L/h; extraction time: 2 h; entrainer: water and ethanol in a volume ratio of 3: 1;
s3, uniformly mixing the water extraction freeze-dried powder obtained in the step S1 and the supercritical fluid extract obtained in the step S2 to obtain the stevia rebaudiana leaf extract, wherein the yield is 85%.
Example 3Preparation of stevia leaf extract
A method for preparing stevia rebaudiana leaf extract comprises the following steps:
s1, pure water extraction: cleaning stevia rebaudiana leaves, cutting into pieces, adding into pure water, soaking, performing ultrasonic-assisted extraction for 30min at the ultrasonic power of 1700W, filtering, retaining filter residues, freeze-drying the filtrate, and cooling to-35 ℃ for 10h after freezing for 30min under the freeze-drying condition of-15 ℃ to obtain water extract freeze-dried powder;
s2, supercritical fluid extraction: filling the filter residue obtained in the step S1 into an extraction kettle, and opening CO2Performing supercritical fluid extraction in a steel cylinder, opening a valve of an extraction kettle after extraction is finished, collecting an extract, and drying at low temperature, wherein the drying at low temperature is-5 ℃ for 1h to obtain a supercritical fluid extract;
the extraction conditions were:
extraction pressure: 22 MPa; the extraction temperature is as follows: 47 ℃; CO 22Flow rate: 7L/h; extraction time: 2 h; entrainer: water and ethanol in a volume ratio of 3: 1;
s3, uniformly mixing the water extraction freeze-dried powder obtained in the step S1 and the supercritical fluid extract obtained in the step S2 to obtain the stevia rebaudiana leaf extract, wherein the yield is 90%.
Comparative example 1
The experimental process parameters were different compared to example 3.
A method for preparing stevia rebaudiana leaf extract comprises the following steps:
s1, pure water extraction: cleaning stevia rebaudiana leaves, cutting into pieces, adding into pure water, soaking, performing ultrasonic-assisted extraction for 10min at the ultrasonic power of 500W, filtering, retaining filter residues, freeze-drying the filtrate, and cooling to-35 ℃ for 10h after freezing for 10min under the freeze-drying condition of-15 ℃ to obtain water extract freeze-dried powder;
s2, supercritical fluid extraction: filling the filter residue obtained in the step S1 into an extraction kettle, and opening CO2Performing supercritical fluid extraction in a steel cylinder, opening a valve of an extraction kettle after extraction is finished, collecting an extract, drying at low temperature, and drying at the low temperature of-5 ℃ for 30min to obtain a supercritical fluid extract;
the extraction conditions were:
extraction pressure: 12 MPa; the extraction temperature is as follows: 27 ℃; CO 22Flow rate: 3L/h; extraction time: 1 h; entrainer: water and ethanol in a volume ratio of 1: 1;
s3, uniformly mixing the water extraction freeze-dried powder obtained in the step S1 and the supercritical fluid extract obtained in the step S2 to obtain the stevia rebaudiana leaf extract, wherein the yield is 20%.
Example 4
Step (1), mixing 100g of stevia rebaudiana extract prepared in example 1, 5g of nutrient, 2g of inulin, 3g of red vinegar, 10g of lemon juice and 2g of carrageenan, adding water, and uniformly stirring to fully dissolve the mixture;
the nutrient material comprises vitamin A, whey protein, pea protein, glycine and alanine, and the mass ratio is 1: 50:30:1:2.
Standing for 24 hours, filtering, adding water to a specified amount, decocting with slow fire while stirring, decocting until the relative density is 3, and stopping heating;
and (3) standing for 24 hours, filling, and sterilizing, wherein the sterilization method is pasteurization, and specifically the syrup is heated to 62 ℃ and kept for 30min to obtain the syrup.
Example 5
Step (1), mixing 100g of stevia rebaudiana extract prepared in example 2, 10g of nutrient materials, 2g of mogroside, 7g of apple vinegar, 20g of apple juice and 5g of agar, adding water, and uniformly stirring to fully dissolve the mixture;
the nutritional material comprises vitamin C, vitamin E, collagen, beef powder, hydrolyzed wheat protein, pea protein, tyrosine and serine in a mass ratio of 3:1:10:20:15:22:1: 2.
Standing for 24 hours, filtering, adding water to a specified amount, decocting with slow fire while stirring, decocting until the relative density is 5, and stopping heating;
and (3) standing for 24 hours, filling, and sterilizing, wherein the sterilization method is pasteurization, and specifically the syrup is heated to 65 ℃ and kept for 30min to obtain the syrup.
And (4) mixing the stevia rebaudiana leaf mixed nutrient syrup into milk and uniformly stirring.
Example 6
Step (1), mixing 100g of stevia leaf extract prepared in example 3, 6g of nutrient material, 2g of erythritol, 4g of persimmon vinegar, 12g of grape juice and 3g of sesbania gum, adding water, and stirring uniformly to fully dissolve the components;
the nutrient material comprises traditional Chinese medicine extract, vitamin C, lactalbumin, tryptophan and tyrosine, and the mass ratio is 10:2:12:1: 2.
The traditional Chinese medicine extract comprises the following raw materials in parts by weight: 100 parts of liquorice, 50 parts of sugarcane and 10 parts of dendrobium officinale.
The traditional Chinese medicine extract is prepared by the following method:
s1, pretreatment: weighing the raw medicinal materials according to a certain proportion, cleaning, drying and crushing to obtain traditional Chinese medicine powder for later use;
s2, extraction: adding 50mL of traditional Chinese medicine powder 10g into pure water, adding cellulase with the addition of 1000U/kg, adjusting the pH value to 5 by using 1mol/L hydrochloric acid, adjusting the temperature to 45 ℃, performing enzymolysis for 0.5h, performing enzyme deactivation, wherein the enzyme deactivation method comprises the steps of heating at 100 ℃ for 10min, adding sodium carbonate to adjust the pH value to be neutral, performing ultrasonic assisted extraction at 1200W for 1h, centrifuging under the centrifugal condition of 4 ℃ and 10000r/min for 5min, collecting supernatant and concentrating, wherein the concentration method comprises the steps of performing ultrafiltration by adopting a ceramic membrane, the aperture of the ceramic membrane is 0.10 mu m, and the operation condition of the ceramic membrane ultrafiltration is as follows: transmembrane pressure difference of 0.30MPa, filtration temperature of 57 deg.C, membrane surface flow rate of 10m/s, and freeze drying at-10 deg.C for 15min and-30 deg.C for 12 hr to obtain Chinese medicinal extract.
Standing for 24 hours, filtering, adding water to a specified amount, decocting with slow fire while stirring, decocting until the relative density is 3.5, and stopping heating;
and (3) standing for 24 hours, filling, and sterilizing, wherein the sterilization method is pasteurization, and specifically the syrup is heated to 63 ℃ and kept for 30min to obtain the syrup.
And (4) mixing the syrup with the black tea jelly uniformly.
Example 7
Step (1), mixing 100g of stevia rebaudiana extract prepared in example 3, 9g of nutrient material, 2g of malt syrup, 6g of black vinegar, 18g of passion fruit juice and 4g of tamarind polysaccharide gum, adding water, and uniformly stirring to fully dissolve the components;
the nutrient material comprises traditional Chinese medicine extract, B vitamins, whey protein, pea protein and proline in a mass ratio of 12:1:15:5:1:2, wherein the B vitamins comprise vitamin B1, vitamin B12 and folic acid in a mass ratio of 5:1: 1.
The traditional Chinese medicine extract comprises the following raw materials in parts by weight: 200 parts of liquorice, 120 parts of sugarcane and 20 parts of dendrobium officinale.
The traditional Chinese medicine extract is prepared by the following method:
s1, pretreatment: weighing the raw medicinal materials according to a certain proportion, cleaning, drying and crushing to obtain traditional Chinese medicine powder for later use;
s2, extraction: adding 10g of traditional Chinese medicine powder into 100mL of pure water, adding cellulase with the addition of 1200U/kg, adjusting the pH value to 5 by using 1mol/L hydrochloric acid, adjusting the temperature to 60 ℃, performing enzymolysis for 1h, and then performing enzyme deactivation, wherein the enzyme deactivation method comprises the steps of heating at 100 ℃ for 10min, adding sodium carbonate to adjust the pH value to be neutral, performing 1500W ultrasonic-assisted extraction for 3h, centrifuging at the centrifugal condition of 4 ℃ and 12000r/min for 5min, collecting supernatant and concentrating, wherein the concentration method comprises the steps of performing ultrafiltration by adopting a ceramic membrane, the aperture of the ceramic membrane is 0.05 mu m, and the operation condition of the ceramic membrane ultrafiltration is as follows: transmembrane pressure difference is 0.17MPa, filtering temperature is 52 ℃, membrane surface flow rate is 7m/sm/s, and freeze drying is carried out under the conditions of freezing at-10 ℃ for 15min and freezing at-30 ℃ for 12h to obtain the traditional Chinese medicine extract.
Standing for 24 hours, filtering, adding water to a specified amount, decocting with slow fire while stirring, decocting until the relative density is 4.5, and stopping heating;
and (3) standing for 24 hours, filling, and sterilizing, wherein the sterilization method is pasteurization, and specifically the syrup is heated to 64 ℃ and kept for 30min to obtain the syrup.
And (4) mixing the syrup into peanut butter and uniformly mixing.
Example 8
Step (1), mixing 100g of stevia rebaudiana extract prepared in example 3, 7g of nutrient material, 2g of sorbitol, 5g of glutinous rice vinegar, 15g of blueberry juice and 3g of acacia, adding water, and stirring uniformly to fully dissolve the mixture;
the nutrient material comprises traditional Chinese medicine extract, vitamin A, vitamin C, lactalbumin and cysteine in a mass ratio of 10:1:2:10: 1.
The traditional Chinese medicine extract comprises the following raw materials in parts by weight: 150 parts of liquorice, 70 parts of sugarcane and 15 parts of dendrobium officinale.
The traditional Chinese medicine extract is prepared by the following method:
s1, pretreatment: weighing the raw medicinal materials according to a certain proportion, cleaning, drying and crushing to obtain traditional Chinese medicine powder for later use;
s2, extraction: adding 70mL of traditional Chinese medicine powder 10g into pure water, adding cellulase with the addition of 1100U/kg, adjusting the pH value to 5 by using 1mol/L hydrochloric acid, adjusting the temperature to 55 ℃, performing enzymolysis for 1h, and then performing enzyme deactivation, wherein the enzyme deactivation method comprises the steps of heating at 100 ℃ for 10min, adding sodium carbonate to adjust the pH value to be neutral, performing ultrasonic-assisted extraction for 2h under 1350W, centrifuging at the centrifugal condition of 4 ℃ and 11000r/min for 5min, collecting supernatant and concentrating, wherein the concentration method comprises the steps of performing ultrafiltration by adopting a ceramic membrane, the aperture of the ceramic membrane is 0.07 mu m, and the operating conditions of the ceramic membrane ultrafiltration are as follows: transmembrane pressure difference of 0.22MPa, filtration temperature of 55 deg.C, membrane surface flow rate of 8m/s, and freeze drying at-10 deg.C for 15min and-30 deg.C for 12 hr to obtain Chinese medicinal extract.
Standing for 24 hours, filtering, adding water to a specified amount, decocting with slow fire while stirring, decocting until the relative density is 4, and stopping heating;
and (3) standing for 24 hours, filling, and sterilizing, wherein the sterilization method is pasteurization, and specifically the syrup is heated to 63 ℃ and kept for 30min to obtain the syrup.
And (4) uniformly mixing the syrup and auxiliary materials, and tabletting to obtain the stevia rebaudiana leaf mixed nutrient syrup tablets.
Comparative example 2
In comparison with example 8, the stevia leaf extract prepared in example 3 was replaced with the stevia leaf extract prepared in comparative example 1, and other materials and preparation methods were the same as example 8.
Comparative example 3
In comparison with example 8, the stevia leaf extract prepared in example 3 was replaced with a general stevia leaf extract, and other materials and preparation methods were the same as example 8. The extract of common stevia rebaudiana leaves is provided by Shaanxi Fuzheng Biotech limited.
Comparative example 4
Compared with the example 8, the nutrient material is not added with the traditional Chinese medicine extract, and other raw materials and the preparation method are the same as the example 8.
The nutrient material comprises vitamin A, vitamin C, lactalbumin and cysteine in a mass ratio of 1:2:20: 1.
Comparative example 5
Compared with the example 8, the nutrient material is not added with whey protein, and other raw materials and the preparation method are the same as the example 8.
The nutrient material is selected from traditional Chinese medicine extract, vitamin A, vitamin C and cysteine, and the mass ratio is 20:1:2: 1.
Test example 1Experimental study for anti-hepatic injury
Experimental materials, instruments and reagents
1. Experimental Material
Stevia rebaudiana leaves are collected from a New Cao farm in east Tai city of Jiangsu province, and are prepared according to the methods of examples 1-3 and comparative example 1 to obtain the stevia rebaudiana leaf extract. Stevia rebaudiana leaf mixed nutrient syrup prepared by the methods of examples 4-8 and comparative examples 2-5.
2. Laboratory apparatus
TG16-WS desk-top high-speed centrifuge, Hunan instrument laboratory Instrument development Co., Ltd; DK-98-1 model electric heating constant temperature water bath, Tianjin Tester instruments, Inc.; continuous Spectroscopy scanning microplate reader SpectraMaxPlus384 USA molecular biology Instrument company.
3. Experimental reagent
CCl4Absolute ethanol, shanghai alatin Biotechnology, ltd; edible soybean oil, alanine Aminotransferase (ALT) kit and aspartate Aminotransferase (AST) kit, SOD kit, MDA kit, Coomassie brilliant blue kit, and Nanjing to build a bioengineering institute.
4. Laboratory animal
Male ICR mice of clean grade, body weight (20. + -. 2) g.
Second, Experimental methods
1. For CCl4Influence of acute liver injury in mice
Mice were acclimatized for one week during which they had free access to water. After one week, the animals were randomly divided into 14 groups of 10 animals by weight, which were: is normalControl group, CCl4Model groups, the stevia rebaudiana leaf extract low dose group (50mg/kg/d) prepared in examples 1-3, the middle dose group (100mg/kg/d), the high dose group (200mg/kg/d), the stevia rebaudiana leaf extract group (100mg/kg/d) prepared in comparative example 1, the stevia rebaudiana leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 4, the stevia rebaudiana leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 5, the stevia rebaudiana leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 6, the stevia rebaudiana leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 7, the stevia rebaudiana leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 8, the stevia rebaudiana leaf mixed nutrient syrup group (100mg/kg/d) prepared in comparative example 2, the stevia rebaudiana leaf mixed nutrient syrup group prepared in comparative example 3 (100mg/kg/d), the stevia rebaudiana leaf mixed nutrient syrup group prepared in comparative example 4 (100mg/kg/d), the stevia rebaudiana leaf mixed nutrient syrup group prepared in comparative example 5 (100mg/kg/d), and the bifendate group (positive control group, 150mg/kg/d), all the drugs were dissolved in normal saline and the dissolution was assisted by ultrasound. Except normal control group and model group, the same amount of normal saline is used for intragastric administration according to body weight, and other administration groups are used for intragastric administration according to body weight. Gavage is performed 1 time per day for 7 days. In the 6 th day, fasting is performed for 12h without water prohibition, and after the normal administration is performed for 1h in the next day, 10% CCl is injected into abdominal cavity of each group except the normal control group4Soybean oil solution to cause acute CCl4Liver damage. After 6h, blood was taken from the eyeball, serum was centrifuged at 4200rpm for 10min, and the supernatant was stored in a refrigerator at 4 ℃. After blood sampling, mice are killed by cervical spondylolysis immediately, livers and spleens are dissected and taken out, after weighing, blood stains on the surfaces of the livers are washed off by normal saline, after the normal saline on the surfaces is wiped off, a part of the livers are soaked and fixed by 10% formalin, and the other part of the livers are wrapped by tinfoil and then are immediately placed into a refrigerator at the temperature of minus 80 ℃ for storage.
Serology and liver index detection: and (3) adding the centrifuged serum into a 96-well plate according to the instructions of ALT and AST kits, measuring the OD value by using an enzyme-labeling instrument, and calculating the activity of ALT and AST in the mouse serum.
Weighing a certain weight of frozen liver, adding cold normal saline according to the weight-volume ratio of 1:9 for homogenizing, centrifuging for 10min at 4200rpm in a refrigerated centrifuge, taking supernatant to obtain 10% of liver homogenate, and preparing the liver homogenate under the low temperature condition. A small amount of 10% liver homogenate was taken and diluted with cold physiological saline to 1% liver homogenate.
Loading samples in a 96-well plate according to the instruction of a Coomassie brilliant blue kit, SOD and MDA kit, respectively, measuring respective OD values by an enzyme labeling instrument, and respectively calculating the concentration of the hepatic protein in 1 percent of liver homogenate, the activity of the SOD in the liver and the concentration of the MDA in 10 percent of the liver homogenate.
2. Influence on acute liver injury of mice caused by alcohol
Mice were acclimatized for one week during which they had free access to water. After one week, the animals were randomly divided into 14 groups of 10 animals by weight, which were: a normal control group, an alcohol model group, a stevia leaf extract low dose group (50mg/kg/d) prepared in examples 1-3, a middle dose group (100mg/kg/d), a high dose group (200mg/kg/d), a stevia leaf extract group (100mg/kg/d) prepared in comparative example 1, a stevia leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 4, a stevia leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 5, a stevia leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 6, a stevia leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 7, a stevia leaf mixed nutrient syrup group (100mg/kg/d) prepared in example 8, the stevia rebaudiana mixed nutrient syrup group prepared in comparative example 2 (100mg/kg/d), the stevia rebaudiana mixed nutrient syrup group prepared in comparative example 3 (100mg/kg/d), the stevia rebaudiana mixed nutrient syrup group prepared in comparative example 4 (100mg/kg/d), the stevia rebaudiana mixed nutrient syrup group prepared in comparative example 5 (100mg/kg/d), and the bifendate group (a positive control group, 150mg/kg/d), all the medicines were dissolved by normal saline and the dissolution was assisted by ultrasound. Except for the blank control group and the model group, the same amount of normal saline is used for intragastric administration according to the body weight, and other administration groups are used for administrating corresponding medicines according to the body weight. Gavage is performed 1 time per day for 7 days. After the administration of the drug for 12h in the evening on the 6 th day, and after the normal administration for 1h on the next day, the rest groups except the blank control group are subjected to intragastric administration of 50% ethanol according to the dose of 12ml/kg to cause acute alcoholic liver injury. After 12h, the eye was bled, the serum was centrifuged at 4200rpm for 10min, and the supernatant was stored in a 4 ℃ refrigerator. After blood sampling, mice are killed by cervical spondylolysis immediately, livers and spleens are dissected and taken out, after weighing, blood stains on the surfaces of the livers are washed off by normal saline, after the normal saline on the surfaces is wiped off, a part of the livers are soaked and fixed by 10% formalin, and the other part of the livers are wrapped by tinfoil and then are immediately placed into a refrigerator at the temperature of minus 80 ℃ for storage.
Serology and liver index detection: and (3) adding the centrifuged serum into a 96-well plate according to the instructions of ALT and AST kits, measuring the OD value by using an enzyme-labeling instrument, and calculating the activity of ALT and AST in the mouse serum.
Weighing a certain weight of frozen liver, adding cold normal saline according to the weight-volume ratio of 1:9 for homogenizing, centrifuging for 10min at 4200rpm in a refrigerated centrifuge, taking supernatant to obtain 10% of liver homogenate, and preparing the liver homogenate under the low temperature condition. A small amount of 10% liver homogenate was taken and diluted with cold physiological saline to 1% liver homogenate.
Loading samples in a 96-well plate according to the instruction of a Coomassie brilliant blue kit, SOD and MDA kit, respectively, measuring respective OD values by an enzyme labeling instrument, and respectively calculating the concentration of the hepatic protein in 1 percent of liver homogenate, the activity of the SOD in the liver and the concentration of the MDA in 10 percent of the liver homogenate.
Third, experimental results
1. For CCl4Influence of acute liver injury in mice
The results of this experiment show that the test is carried out by CCl4After injection, ALT and AST of the model mice are obviously increased and higher than those of the normal control group, which indicates that the model building is successful (p)<0.05), high dose, medium dose groups, and the groups given in examples 4-6 all reduced the increased ALT and AST activity in serum with significant differences (p) compared to the model group<0.05), examples 7-8 had very significant differences (p)<0.01); meanwhile, the high and medium dose groups of stevia rebaudiana leaf extract and the groups of examples 4-6 can effectively reduce the MDA level and increase the SOD level of liver tissues, and have significant difference (p)<0.05), examples 7-8 had very significant differences (p)<0.01), groups of comparative examples 1 to 5 had a decreasing trend and were not statistically significant (p)>0.05). Specific results are shown in table 1.
TABLE 1 influence of stevia rebaudiana leaf extract on serum ALT and AST and liver SOD and MDA of mice with CCl4 acute liver injury
Note that: #, dosing vs model group, p < 0.05; ﹡, dosing group vs model group, p <0.05, administration group vs model group, p < 0.01.
2. Influence on acute liver injury of mice caused by alcohol
The experimental result shows that after the stomach is perfused by 50% alcohol, ALT and AST of the model group mice are obviously increased and higher than those of a normal control group, which indicates that the model building is successful (p is less than 0.05), and the high-dose and medium-dose groups and the administration groups of examples 4-6 are compared with the model group, so that the ALT and AST activities increased in serum can be reduced, and the test results show that the test results have significant differences (p is less than 0.05), and the test results show that the test results in examples 7-8 have very significant differences (p is less than 0.01); meanwhile, the stevia rebaudiana leaf extract high and medium dose groups and the groups of examples 4 to 6 can effectively reduce the MDA level and increase the SOD level of the liver tissue, have significant difference (p <0.05), have extremely significant difference (p <0.01) in examples 7 to 8, have reduction trend in the groups of comparative examples 1 to 5, and have no statistical significance (p > 0.05). The specific results are shown in Table 2.
TABLE 2 influence of stevia rebaudiana leaf extract on serum ALT and AST and liver SOD and MDA of mice with acute liver injury caused by alcohol
Note that: #, dosing vs model group, p < 0.05; ﹡, dosing group vs model group, p <0.05, administration group vs model group, p < 0.01.
Fourth, conclusion of experiment
Stevia leaf extract prepared in examples 1 to 3, stevia leaf sugar prepared in examples 4 to 8 of the present inventionThe pulp can obviously reduce CCl4Or ALT and AST activity in serum of a model mouse with alcohol-induced liver injury and liver tissue MDA content, and liver SOD activity are enhanced, which shows that the active extract has obvious liver protection effect on chemical liver injury and alcoholic liver injury.
Comparative example 1 the preparation process differs from the inventive example 3 in that the stevia rebaudiana leaf extract prepared has a low yield and a poor activity of protecting liver, and has a tendency of recovering various indexes of liver, but is not obvious.
Comparative example 2 stevia leaf syrup prepared using the stevia leaf extract prepared in comparative example 1 also has poor activity of protecting liver.
Comparative example 3 compared to example 8, the stevia leaf extract prepared in example 3 was replaced with a general stevia leaf extract, and there was almost no activity of protecting liver.
Compared with the example 8, the comparative examples 4 and 5 are not added with the traditional Chinese medicine extract and the whey protein respectively, the activity of protecting the liver is poorer, although various indexes of the liver are recovered, the activity is not obvious, and the activity is obviously reduced greatly compared with the example 6. Therefore, the traditional Chinese medicine extract and the whey protein have synergistic effect.
Test example 2Blood sugar reduction experiment of stevia rebaudian leaf extract
1 materials and methods
1.1 materials
SPF-grade KM mice, male, (22 ± 2) g, purchased from slagoff test animals limited, hunan, production license number: SCXK (Xiang) 2018-.
1.2 Experimental methods
1.2.1 method for establishing hyperglycemic mouse model
SPF-grade KM male mice, about 22g, were fed with free diet for 3 days. Fasting for 16h, measuring fasting blood glucose and body weight, determining required streptozotocin amount according to body weight, preparing solution, and performing intraperitoneal injection of 50mg/kg-1Injections were given for 5 days 1 time per day. After the last injection, fasting for 16h, measuring blood sugar and bloodThe sugar value is higher than 11.1 mmoL.L-1The molding is regarded as successful; meanwhile, the physiological changes of the weight, drinking water, diet and the like of the mice are observed and recorded.
1.2.2 animal test design
Based on the established hyperglycemic mouse model method, 42 SPF-level KM mice are adaptively raised for 7 days at 22-25 ℃, weighed, 6 mice are randomly selected as normal groups, the rest mice are modeled, and 36 mice successfully modeled are randomly divided into a model group and a stevia rebaudiana extract high-dose group (the dose is 700mg kg. kg)-1·d-1) And stevia leaf extract middle dose group (dose is 350mg kg)-1·d-1) Stevia leaf extract low dose group (dose of 175mg kg)-1·d-1) The traditional Chinese medicine composition comprises a high-dose group of common stevia leaf extract and 6 metformin hydrochloride groups. The normal group and the model group are fed with water with equal volume, and the feeding volume is 10 mL/kg-1·d-1The mice were continuously fed with 28d, and the blood glucose levels of the mice in each group were measured at 7, 14, 21, and 28d, respectively.
1.2.3 data processing was performed using SPSS 22.0 software and results are expressed as "mean. + -. standard deviation (x. + -. sd)". The difference between groups is analyzed by adopting ONE-WAY analysis of variance (ONE-WAY ANOVA) and Duncan multiple comparison, wherein p is less than 0.05 to indicate that the difference is obvious, and p is less than 0.01 to indicate that the difference is extremely obvious. Correlation analysis was performed by Pearson's method.
2. Effects on blood glucose in hyperglycemic mice
The results are shown in FIG. 1, note: significant differences (p <0.01) compared to normal group; compared with the model group, # indicates significant difference (p <0.05) and # indicates very significant difference (p < 0.01).
As can be seen from FIG. 1, the blood glucose levels of the mice in each group before molding were all at normal levels, and the fasting blood glucose levels of the mice in each group after molding were significantly increased (P <0.01), and the blood glucose levels were all higher than 11.1 mmoL.L-1Thus, the success of modeling the hyperglycemia model is demonstrated. After 28 days of feeding, compared with the model group, the blood sugar level of the stevia leaf extract in the high and medium dose groups and the metformin hydrochloride group is extremely reduced (P is less than 0.01), and the blood sugar level of the low dose group is significantly reduced (P is less than 0.05), thereby indicating that the sweet taste is generatedThe chrysanthemum syrup has obvious blood sugar reducing effect. The blood sugar of mice in the common stevia syrup group is slightly reduced, and the difference with the model group is not obvious, which indicates that the common stevia syrup does not have obvious blood sugar reducing effect.
Compared with the prior art, the method adopts water soaking and supercritical fluid extraction to prepare the active extract of the stevia rebaudiana leaf on the basis of the research on the original chemical components and the traditional efficacy of the stevia rebaudiana leaf, and compared with the prior art, the extracted stevia rebaudiana leaf extract can obviously reduce CCl4Or ALT and AST activity in serum of a model mouse with alcohol-induced liver injury and liver tissue MDA content, and liver SOD activity are enhanced, which shows that the active extract has obvious liver protection effect on chemical liver injury and alcoholic liver injury. Therefore, the stevia rebaudiana leaf extract is expected to be developed into a new generation of safe and effective medicine, health-care product or food for preventing and treating various types of liver protection.
The stevia rebaudiana leaf syrup provided by the invention reduces the sugar content of the syrup, the stevioside component can obviously improve the sweetness of the syrup without increasing the blood sugar content of eaters, can be eaten by patients with diabetes, essential hypertension, hyperglycemia and hyperlipidemia, further has the effects of reducing blood pressure, blood sugar and blood fat and the like, and has wide application prospect.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (10)
1. A preparation method of stevia rebaudiana leaf mixed nutrient syrup is characterized in that the syrup at least comprises stevia rebaudiana leaf extract, nutrient extract, sweetener, brewed vinegar, fruit juice and a flavoring agent, and the preparation method comprises the following steps:
step (1), mixing stevia rebaudiana leaf extract, nutrient materials, sweetener, brewed vinegar, fruit juice and a regulator, adding water, and stirring uniformly to fully dissolve the mixture;
standing for 24 hours, filtering, adding water to a specified amount, decocting with slow fire while stirring, decocting until the relative density is 3-5, and stopping heating;
and (3) standing for 24 hours, filling and sterilizing to obtain the product.
2. The method of claim 1, wherein the stevia rebaudiana leaf extract is prepared by:
s1, cleaning stevia rebaudiana leaves, cutting into pieces, adding the stevia rebaudiana leaves into pure water for soaking, performing ultrasonic-assisted extraction for 30min, filtering, reserving filter residues, and freeze-drying the filtrate to obtain water extract freeze-dried powder;
s2, filling the filter residue obtained in the step S1 into an extraction kettle, and opening CO2The steel cylinder is used for carrying out supercritical fluid extraction, after the extraction is finished, a valve of the extraction kettle is opened, the extract is collected and dried at low temperature, and the supercritical fluid extract is obtained;
the extraction conditions were:
extraction pressure: 21-24 MPa; the extraction temperature is as follows: 45-50 ℃; CO 22Flow rate: 6-9L/h; extraction time: 2 h; entrainer: water and ethanol in a volume ratio of 3: 1;
s3, uniformly mixing the water extraction freeze-dried powder obtained in the step S1 and the supercritical fluid extract obtained in the step S2 to obtain the stevia rebaudiana leaf extract.
3. The method for preparing the stevia rebaudiana leaf mixed nutrient syrup as claimed in claim 2, wherein the ultrasonic power is 1500-2000W, the freeze drying condition is that the mixture is frozen at-15 ℃ for 30min and then cooled to-35 ℃ for 10h, and the low-temperature drying is drying at-5 ℃ for 1 h.
4. The preparation method of the stevia rebaudiana leaf mixed nutrient syrup according to claim 1, wherein the mass ratio of the stevia rebaudiana leaf extract to the nutrient to the sweetener to the brewed vinegar to the fruit juice to the flavoring agent is 100 (5-10): 2: (3-7): (10-20): (2-5).
5. The method for preparing mixed nutrient syrup of stevia rebaudiana leaves as claimed in claim 1, wherein the nutrient is selected from one or more of Chinese medicinal extracts, vitamins, animal proteins, plant proteins and amino acids.
6. The method for preparing stevia rebaudiana leaf mixed nutrient syrup as claimed in claim 5, wherein the traditional Chinese medicine extract comprises the following raw materials in parts by weight: 100-200 parts of liquorice, 50-120 parts of sugarcane and 10-20 parts of dendrobium officinale.
7. The method for preparing stevia rebaudiana leaf mixed nutrient syrup as claimed in claim 5, wherein the Chinese herbal extract is prepared by the following method:
s1, pretreatment: weighing the raw medicinal materials according to a certain proportion, cleaning, drying and crushing to obtain traditional Chinese medicine powder for later use;
s2, extracting: adding the Chinese medicinal powder into pure water, adding cellulase, adjusting pH and temperature, performing enzymolysis for 0.5-1 hr, inactivating enzyme, adding sodium carbonate to adjust pH to neutral, performing ultrasonic-assisted extraction for 1-3 hr, centrifuging, collecting supernatant, concentrating, and freeze drying to obtain Chinese medicinal extract.
8. The method for preparing mixed nutrient syrup of stevia rebaudiana leaves as claimed in claim 7, wherein the pH value is adjusted to 5, the temperature is adjusted to 45-60 ℃, the enzyme deactivation method is heating at 100 ℃ for 10min, the ultrasonic power is 1200-: (5-10); the addition amount of the cellulase is 1000-1200U/kg, the concentration method adopts ceramic membrane ultrafiltration, the aperture of the ceramic membrane is 0.05-0.10 mu m, and the operation conditions of the ceramic membrane ultrafiltration are as follows: the transmembrane pressure difference is 0.17-0.30MPa, the filtration temperature is 52-57 ℃, and the membrane surface flow rate is 7-10 m/s.
9. Use of a stevia rebaudiana leaf mixed nutrient syrup prepared by the method of any one of claims 1 to 8 in the preparation of a medicament, health food or food for preventing and treating liver injury.
10. The use of claim 9, wherein the liver injury is chemical liver injury or alcoholic liver injury.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911288732.4A CN110959863A (en) | 2019-12-13 | 2019-12-13 | Stevia rebaudiana leaf mixed nutrient syrup and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911288732.4A CN110959863A (en) | 2019-12-13 | 2019-12-13 | Stevia rebaudiana leaf mixed nutrient syrup and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110959863A true CN110959863A (en) | 2020-04-07 |
Family
ID=70034251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911288732.4A Pending CN110959863A (en) | 2019-12-13 | 2019-12-13 | Stevia rebaudiana leaf mixed nutrient syrup and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110959863A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114601172A (en) * | 2022-03-10 | 2022-06-10 | 山东若尧特医食品有限公司 | Formula food of glutamine composition with special medical application and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0335265A2 (en) * | 1988-03-29 | 1989-10-04 | Udo Kienle | Process for the preparation of a natural sweetening agent derived from stevia rebaudiana |
CN101062077A (en) * | 2007-06-18 | 2007-10-31 | 石任兵 | Method for preparing stevia whole stevioside and stevia whole flavone at the same time |
CN101693047A (en) * | 2009-10-20 | 2010-04-14 | 天津科技大学 | New method for extracting general stevioside of stevia rebaudiana under ultrahigh pressure |
CN106046075A (en) * | 2016-06-17 | 2016-10-26 | 蚌埠市华东生物科技有限公司 | Method for extracting stevioside from stevia rebaudiana leaves |
-
2019
- 2019-12-13 CN CN201911288732.4A patent/CN110959863A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0335265A2 (en) * | 1988-03-29 | 1989-10-04 | Udo Kienle | Process for the preparation of a natural sweetening agent derived from stevia rebaudiana |
CN101062077A (en) * | 2007-06-18 | 2007-10-31 | 石任兵 | Method for preparing stevia whole stevioside and stevia whole flavone at the same time |
CN101693047A (en) * | 2009-10-20 | 2010-04-14 | 天津科技大学 | New method for extracting general stevioside of stevia rebaudiana under ultrahigh pressure |
CN106046075A (en) * | 2016-06-17 | 2016-10-26 | 蚌埠市华东生物科技有限公司 | Method for extracting stevioside from stevia rebaudiana leaves |
Non-Patent Citations (2)
Title |
---|
WANGXUE: "甜叶菊的功效与作用及食用方法", 《果蔬百科(HTTPS://Z.XIZIWANG.NET/SHUCAI/48842/)》 * |
WANGXUE: "甜叶菊的功效与作用及食用方法", 《果蔬百科(HTTPS://Z.XIZIWANG.NET/SHUCAI/48842/)》, 18 November 2018 (2018-11-18), pages 1 - 2 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114601172A (en) * | 2022-03-10 | 2022-06-10 | 山东若尧特医食品有限公司 | Formula food of glutamine composition with special medical application and preparation method thereof |
CN114601172B (en) * | 2022-03-10 | 2024-03-19 | 山东若尧特医食品有限公司 | Formula food with special medical application of glutamine composition and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100989869B1 (en) | Composition for dissolving hangover containing fermented bean sprouts juice | |
CN105613889A (en) | Preparation method of persimmon calyx and pueraria flower healthcare caffeine | |
CN107183433B (en) | Pitaya juice and processing method thereof | |
KR101979698B1 (en) | Composition for preventing, improving treating intestinal function depression comprising hydrolyzed and fermented bamboo sprout as an effective ingredient | |
JP2006045212A (en) | Oral composition containing specific quinic acid derivative | |
KR20160017223A (en) | Composition for muscle development and muscle fatigue recovery comprising Angelica keiskei extract and Red ginseng extract as active ingradients | |
CN110897147A (en) | Dendrobium officinale alcohol-dispelling and liver-protecting composition and preparation method thereof | |
KR101774769B1 (en) | Composition for medicinal herbal tea and manufacturing method of composition for medicinal herbal by supercritical fluid extraction and manufacturing method of carbonated beverage and health beverage thereof | |
CN112450337B (en) | Preparation method of charcoal-roasted milk beverage with antioxidant function from extract of Piteguo and astragalus membranaceus | |
CN106359734A (en) | Sugar-free tea drink with weight-losing function and making method thereof | |
CN108651786A (en) | A kind of preparation method of full nutritional sea buckthorn fruit juice | |
CN110959863A (en) | Stevia rebaudiana leaf mixed nutrient syrup and preparation method and application thereof | |
JP2006045213A (en) | Oral composition containing specific quinic acid derivative | |
CN107495020A (en) | A kind of suitable polypeptide beverage water of diabetic population and its preparation technology | |
KR102149254B1 (en) | Pharnaceutical composition for prevention or treatment of diabetes comprising the mixed extract of vegetable natural products having the effect on removal of swelling and health functional food for prevention or improvement of diabetes comprising the same | |
KR101732456B1 (en) | Three steps complex fermented crude liquid and manufacturing method thereof | |
KR101513240B1 (en) | A composition comprising extracts of herbal mixture for fatigue recovery as in gradient compounds | |
KR101350046B1 (en) | Vinegar composition fermented with herbal extracts and preparation method thereof | |
CN110934243A (en) | Preparation method of novel health-care hand-operated beverage | |
CN115104730A (en) | Composition for improving sleep, sparrow leucomelas-asparagus sleep improvement liquid and tea powder preparation method and application | |
JP2006256969A (en) | Blood flow ameliorant | |
CN111011854A (en) | Wolfberry extract and preparation method and application thereof | |
CN107950829A (en) | A kind of leaf of Moringa taraxacum health beverage and preparation method thereof | |
KR102514704B1 (en) | Manufacturing method of food compositon comprising plant extracts for inhibiting obesity | |
CN114409816B (en) | Chicory root polysaccharide, extraction method thereof and preparation method of blood glucose reducing beverage containing chicory root polysaccharide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200407 |
|
RJ01 | Rejection of invention patent application after publication |